Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.

Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.

Amino-myo-inositol derivatives have been found to be potent inhibitors of glucocerebrosidase (GCase), the β-glucosidase enzyme deficient in Gaucher disease (GD). When tested using lymphoblasts derived from patients with GD homozygous for N370S or L444P mutations, the compounds enhanced GCase activit...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Trapero, A, González-Bulnes, P, Butters, T, Llebaria, A
פורמט:	Journal article
שפה:	English
יצא לאור:	2012

פריטים דומים

Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.
מאת: Trapero, A, et al.
יצא לאור: (2011)

Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism
מאת: Benjamin McMahon, et al.
יצא לאור: (2016-01-01)

Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
מאת: Wang, G, et al.
יצא לאור: (2009)

Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
מאת: Wang, G, et al.
יצא לאור: (2012)

Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease
מאת: Jinlong Jian, et al.
יצא לאור: (2016-11-01)

Effect of macrophage-targeted glucocerebrosidase(alglucerase) on hypolipidaemia of type 1 Gaucher disease(GD)
מאת: Mistry, P, et al.
יצא לאור: (1997)

Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease
מאת: Kato, A, et al.
יצא לאור: (2016)

Abstract P-43: Effect of Glucocerebrosidase Dysfunction on the Pool of Plasma Exosomes of Patients with Gaucher Disease
מאת: Luiza A. Garaeva, et al.
יצא לאור: (2021-06-01)

N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
מאת: Désiré, J, et al.
יצא לאור: (2014)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
מאת: Figueiredo, Lílian L. S., et al.
יצא לאור: (2024)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
מאת: Lílian L. Souza Figueiredo, et al.
יצא לאור: (2024-10-01)

Gaucher disease.
מאת: Butters, T
יצא לאור: (2007)

Concise and enantioselective synthesis of the aminocyclitol core of hygromycin A.
מאת: Donohoe, T, et al.
יצא לאור: (2005)

Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients
מאת: Keatdamrong Janpipatkul, et al.
יצא לאור: (2024-10-01)

High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase.
מאת: Ehud Goldin, et al.
יצא לאור: (2012-01-01)

in silico identification of genetic variants in glucocerebrosidase (GBA) gene involved in Gaucher’s disease using multiple software tools.
מאת: Madhumathi eManickam, et al.
יצא לאור: (2014-05-01)

A myo-inositol dehydrogenase involved in aminocyclitol biosynthesis of hygromycin A
מאת: Michael O. Akintubosun, et al.
יצא לאור: (2024-03-01)

Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
מאת: Diot, J, et al.
יצא לאור: (2011)

A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
מאת: Wendy Westbroek, et al.
יצא לאור: (2016-07-01)

INVESTIGATIONS ON THE RESISTANCE OF COMMENSAL SWINE ESCHERICHIA COLI TO SOME AMINOGLYCOSIDES-AMINOCYCLITOLS
מאת: Valentina Urumova, et al.
יצא לאור: (2016-03-01)

Second-Generation Pharmacological Chaperones: Beyond Inhibitors
מאת: My Lan Tran, et al.
יצא לאור: (2020-07-01)

Hydrophobic Rose Bengal Derivatives Exhibit Submicromolar-to-Subnanomolar Activity against Enveloped Viruses
מאת: Anna A. Rubekina, et al.
יצא לאור: (2022-11-01)

Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
מאת: Jan Philipp Dobert, et al.
יצא לאור: (2024-07-01)

A NOVEL SYNTHETIC AND RECOMBINANT GLUCOCEREBROSIDASE FOR GAUCHER DISEASE: IN SILICO MOLECULAR EVOLUTION AND GENE THERAPY APPROACHES TO ENHANCE ENZYME ACTIVITY
מאת: LLS Figueiredo, et al.
יצא לאור: (2023-10-01)

Regioselectivity in the Ring Opening of Epoxides for the Synthesis of Aminocyclitols from D-(-)-Quinic Acid
מאת: Shu-Yu Yang, et al.
יצא לאור: (2012-04-01)

Design of a New α-1-C-Alkyl-DAB Derivative Acting as a Pharmacological Chaperone for β-Glucocerebrosidase Using Ligand Docking and Molecular Dynamics Simulation
מאת: Izumi Nakagome, et al.
יצא לאור: (2018-10-01)

Different and unusual presentation of Gaucher’s disease with the same mutation in the glucocerebrosidase enzyme (F266L) in two patients: a case report
מאת: Bijan Keikhaei, et al.
יצא לאור: (2024-11-01)

Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
מאת: Brumshtein, B, et al.
יצא לאור: (2007)

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
מאת: Alba Navarro-Romero, et al.
יצא לאור: (2022-10-01)

Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis
מאת: J I Ruiz, et al.
יצא לאור: (1997-07-01)

Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
מאת: Tae-Un Han, et al.
יצא לאור: (2020-05-01)

Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
מאת: Margarita M. Ivanova, et al.
יצא לאור: (2021-01-01)

Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
מאת: Emilia M. Gatto, et al.
יצא לאור: (2019-02-01)

Comparative Study of Erythrocyte Sedimentation Rate after Aminoglycoside and Aminocyclitol Treatment in Goats (Capra hircus)
מאת: Toncho DINEV, et al.
יצא לאור: (2016-07-01)

Unveiling the Role of Cholesterol in Subnanomolar Ouabain Rescue of Cortical Neurons from Calcium Overload Caused by Excitotoxic Insults
מאת: Dmitry A. Sibarov, et al.
יצא לאור: (2023-08-01)

Structural determinants for subnanomolar inhibition of the secreted aspartic protease Sapp1p from Candida parapsilosis
מאת: Jiří Dostál, et al.
יצא לאור: (2021-01-01)

Imino sugar therapy for type 1 Gaucher disease.
מאת: Priestman, D, et al.
יצא לאור: (2000)

N,Zn-Doped Fluorescent Sensor Based on Carbon Dots for the Subnanomolar Detection of Soluble Cr(VI) Ions
מאת: Enoch Kwasi Adotey, et al.
יצא לאור: (2023-02-01)

Mitochondrial dysfunction associated with glucocerebrosidase deficiency
מאת: Matthew E. Gegg, et al.
יצא לאור: (2016-06-01)

Glucocerebrosidase and its relevance to Parkinson disease
מאת: Jenny Do, et al.
יצא לאור: (2019-08-01)